Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Void · Coders disagree

Rules 1.1.0 · as of 14 Sep 2026

Christian Angermayer · Said 14 Jan 2026 · angermayer-0149

Quote

“Most important: Q1 will be very busy and provide strong news flow, for example Phase 2a data for EMP-01 (R-MDMA) and the End-of-Phase-2b FDA meeting for BPL-003.”
· Christian Angermayer on X: As I got a few DMs and questions here regarding latest $ATAI share price weakness · tweet

Responding to DMs about $ATAI share price weakness, Angermayer lists the Q1 2026 catalysts he expects: EMP-01 Phase 2a readout and the BPL-003 End-of-Phase-2b FDA meeting. Restates milestones from his Oct 2025 substack but in a new source and date.

← Earlier · Later → · All statements